European headache federation guideline on idiopathic intracranial hypertension

Jan Hoffmann; Susan P Mollan; Koen Paemeleire; Christian Lampl; Rigmor H Jensen; Alexandra J Sinclair

doi:10.1186/s10194-018-0919-2

European headache federation guideline on idiopathic intracranial hypertension

Jan Hoffmann, Susan P Mollan, Koen Paemeleire, Christian Lampl, Rigmor H Jensen, Alexandra J Sinclair

Afdeling for Hjerne- og Nervesygdomme

131 Citationer (Scopus)

Abstract

BACKGROUND: Idiopathic Intracranial Hypertension (IIH) is characterized by an elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely unknown, however observations made in a number of recent clinical studies are increasing the understanding of the disease and now provide the basis for evidence-based treatment strategies.

METHODS: The Embase, CDSR, CENTRAL, DARE and MEDLINE databases were searched up to 1st June 2018. We analyzed randomized controlled trials and systematic reviews that investigate IIH.

RESULTS: Diagnostic uncertainty, headache morbidity and visual loss are among the highest concerns of clinicians and patients in this disease area. Research in this field is infrequent due to the rarity of the disease and the lack of understanding of the underlying pathology.

CONCLUSIONS: This European Headache Federation consensus paper provides evidence-based recommendations and practical advice on the investigation and management of IIH.

Originalsprog	Engelsk
Tidsskrift	Journal of Headache and Pain
Vol/bind	19
Udgave nummer	1
Sider (fra-til)	93
ISSN	1129-2377
DOI	https://doi.org/10.1186/s10194-018-0919-2
Status	Udgivet - 2018

Adgang til dokumentet

10.1186/s10194-018-0919-2

Citationsformater

@article{eb9e83dc0d8348e190bdc14c7defe712,

title = "European headache federation guideline on idiopathic intracranial hypertension",

abstract = "BACKGROUND: Idiopathic Intracranial Hypertension (IIH) is characterized by an elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely unknown, however observations made in a number of recent clinical studies are increasing the understanding of the disease and now provide the basis for evidence-based treatment strategies.METHODS: The Embase, CDSR, CENTRAL, DARE and MEDLINE databases were searched up to 1st June 2018. We analyzed randomized controlled trials and systematic reviews that investigate IIH.RESULTS: Diagnostic uncertainty, headache morbidity and visual loss are among the highest concerns of clinicians and patients in this disease area. Research in this field is infrequent due to the rarity of the disease and the lack of understanding of the underlying pathology.CONCLUSIONS: This European Headache Federation consensus paper provides evidence-based recommendations and practical advice on the investigation and management of IIH.",

keywords = "Headache/etiology, Humans, Pseudotumor Cerebri/etiology, Randomized Controlled Trials as Topic",

author = "Jan Hoffmann and Mollan, {Susan P} and Koen Paemeleire and Christian Lampl and Jensen, {Rigmor H} and Sinclair, {Alexandra J}",

year = "2018",

doi = "10.1186/s10194-018-0919-2",

language = "English",

volume = "19",

pages = "93",

journal = "Journal of Headache and Pain",

issn = "1129-2377",

publisher = "SpringerOpen",

number = "1",

}

TY - JOUR

T1 - European headache federation guideline on idiopathic intracranial hypertension

AU - Hoffmann, Jan

AU - Mollan, Susan P

AU - Paemeleire, Koen

AU - Lampl, Christian

AU - Jensen, Rigmor H

AU - Sinclair, Alexandra J

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Idiopathic Intracranial Hypertension (IIH) is characterized by an elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely unknown, however observations made in a number of recent clinical studies are increasing the understanding of the disease and now provide the basis for evidence-based treatment strategies.METHODS: The Embase, CDSR, CENTRAL, DARE and MEDLINE databases were searched up to 1st June 2018. We analyzed randomized controlled trials and systematic reviews that investigate IIH.RESULTS: Diagnostic uncertainty, headache morbidity and visual loss are among the highest concerns of clinicians and patients in this disease area. Research in this field is infrequent due to the rarity of the disease and the lack of understanding of the underlying pathology.CONCLUSIONS: This European Headache Federation consensus paper provides evidence-based recommendations and practical advice on the investigation and management of IIH.

AB - BACKGROUND: Idiopathic Intracranial Hypertension (IIH) is characterized by an elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely unknown, however observations made in a number of recent clinical studies are increasing the understanding of the disease and now provide the basis for evidence-based treatment strategies.METHODS: The Embase, CDSR, CENTRAL, DARE and MEDLINE databases were searched up to 1st June 2018. We analyzed randomized controlled trials and systematic reviews that investigate IIH.RESULTS: Diagnostic uncertainty, headache morbidity and visual loss are among the highest concerns of clinicians and patients in this disease area. Research in this field is infrequent due to the rarity of the disease and the lack of understanding of the underlying pathology.CONCLUSIONS: This European Headache Federation consensus paper provides evidence-based recommendations and practical advice on the investigation and management of IIH.

KW - Headache/etiology

KW - Humans

KW - Pseudotumor Cerebri/etiology

KW - Randomized Controlled Trials as Topic

U2 - 10.1186/s10194-018-0919-2

DO - 10.1186/s10194-018-0919-2

M3 - Journal article

C2 - 30298346

SN - 1129-2377

VL - 19

SP - 93

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

IS - 1

ER -

European headache federation guideline on idiopathic intracranial hypertension

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater